Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment ...

earlier this year to undertake the Phase 1 clinical trial in patients with recurrent glioblastoma. Dr Mulholland, the trial's Chief Investigator, said: "We have been working with Ariceum Therapeutics ...

In the phase ... GLP-1 seeing an improvement in liver fibrosis without worsening of MASH, compared to 29.2% of patients who saw improvement in the study’s control arm. On that midstage trial ...

Essa Pharma’s sole clinical-stage candidate was on track to fall short against Xtandi in a phase 2 prostate cancer trial ... fell short in a phase 1 prostate cancer study.

UCB’s bepranemab slowed the accumulation of tau in the brain but did not slow disease progression in its first phase II test ... bepranemab results at the Clinical Trials on Alzheimer's Disease ...

earlier this year to undertake the Phase 1 clinical trial in patients with recurrent glioblastoma. Dr Mulholland, the trial’s Chief Investigator, said: “We have been working with Ariceum Therapeutics ...

Demand for weight loss drugs targeting GLP-1 has exploded in ... successfully completed a phase 2 clinical trial as a treatment for obesity, and the company will meet with the FDA next month to ...

today announced results from its Phase 1 clinical trial of VENT-03, the first cyclic GMP-AMP synthase (cGAS) inhibitor to successfully complete a first-in-human study. The Phase 1 trial evaluated ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice This open-label, ...

KUALA LUMPUR, Oct 30 —- Former prime minister Datuk Seri Najib Razak will be calling at least 11 witnesses to the High Court to testify in his defence in his 1Malaysia Development Berhad (1MDB) trial, ...

The results of a new clinical trial have overturned the “wait and ... a higher risk of heart attack and stroke, according to a study that has researchers and experts concerned.

The Phase IIa trial (NCT05496374 ... per millilitre (CFU/mL), the study’s primary endpoint. Potential dose-limiting “safety issues”, including three cases of Grade 3 hepatotoxicity, were seen in ...